EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Levodopa-loaded nanoparticles for the treatment of Parkinson's disease

Emile F van Vliet, Maarten J Knol, Raymond M Schiffelers, Massimiliano Caiazzo, Marcel H A M Fens

Journal of Controlled Release · 2023-08 · 360 · 212-224

DOI: 10.1016/j.jconrel.2023.06.026 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Controlled Release, 2023-08. Verfasst von Emile F van Vliet und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, 3584 CG Utrecht, the Netherlands. Hauptthemen laut MEDLINE: Parkinson Disease, Nanoparticles. Die Arbeit wurde bisher 89-mal zitiert (Crossref) und nennt 125 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Parkinson's disease (PD) is a neurodegenerative disorder characterized by degeneration of dopaminergic neurons in the substantia nigra pars compacta (SNpc) resulting in dopamine (DA) deficiency, which manifests itself in motor symptoms including tremors, rigidity and bradykinesia. Current PD treatments aim at symptom reduction through oral delivery of levodopa (L-DOPA), a precursor of DA. However, L-DOPA delivery to the brain is inefficient and increased dosages are required as the disease progresses, resulting in serious side effects like dyskinesias. To improve PD treatment efficacy and to reduce side effects, recent research focuses on the encapsulation of L-DOPA into polymeric- and lipid-based nanoparticles (NPs). These formulations can protect L-DOPA from systemic decarboxylation into DA and improve L-DOPA delivery to the central nervous system. Additionally, NPs can be modified with proteins, peptides and antibodies specifically targeting the blood-brain barrier (BBB), thereby reducing required dosages and free systemic DA. Alternative delivery approaches for NP-encapsulated L-DOPA include intravenous (IV) administration, transdermal delivery using adhesive patches and direct intranasal administration, facilitating increased therapeutic DA concentrations in the brain. This review provides an overview of the recent advances for NP-mediated L-DOPA delivery to the brain, and debates challenges and future perspectives on the field.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseNanoparticlesHumansLevodopaDopamineBrain

Stichwörter der Autor:innen

Blood-brain barrierDrug deliveryIntranasal brain deliveryLipid nanoparticlesPolymeric nanoparticles

Substanzen

LevodopaDopamine

Autor:innen und Institutionen

  • Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, 3584 CG Utrecht, the Netherlands.
  • CDL Research, University Medical Center Utrecht, 3508 GA Utrecht, the Netherlands. Electronic address: R.Schiffelers@umcutrecht.nl.
  • Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, 3584 CG Utrecht, the Netherlands; Department of Molecular Medicine and Medical Biotechnology, University of Naples "Federic…
  • Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, 3584 CG Utrecht, the Netherlands. Electronic address: m.h.a.m.fens@uu.nl.

Zitieren

APA

van Vliet, E. F., Knol, M. J., Schiffelers, R. M., Caiazzo, M., & Fens, M. H. A. M. (2023). Levodopa-loaded nanoparticles for the treatment of Parkinson's disease. Journal of Controlled Release, 360, 212-224. https://doi.org/10.1016/j.jconrel.2023.06.026

Vancouver

van Vliet EF, Knol MJ, Schiffelers RM, Caiazzo M, Fens MHAM. Levodopa-loaded nanoparticles for the treatment of Parkinson's disease. Journal of Controlled Release. 2023;360:212-224. doi:10.1016/j.jconrel.2023.06.026

BibTeX
@article{vanVliet2023,
  author = {van Vliet, Emile F and Knol, Maarten J and Schiffelers, Raymond M and Caiazzo, Massimiliano and Fens, Marcel H A M},
  title = {Levodopa-loaded nanoparticles for the treatment of Parkinson's disease},
  journal = {Journal of Controlled Release},
  year = {2023},
  volume = {360},
  pages = {212--224},
  doi = {10.1016/j.jconrel.2023.06.026}
}
Kostenlos starten →